» Articles » PMID: 18322269

Cadherin Switching

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2008 Mar 7
PMID 18322269
Citations 427
Authors
Affiliations
Soon will be listed here.
Abstract

The cadherin molecules at adherens junctions have multiple isoforms. Cadherin isoform switching (cadherin switching) occurs during normal developmental processes to allow cell types to segregate from one another. Tumor cells often recapitulate this activity and the result is an aggressive tumor cell that gains the ability to leave the site of the tumor and metastasize. At present, we understand some of the mechanisms that promote cadherin switching and some of the pathways downstream of this process that influence cell behavior. Specific cadherin family members influence growth-factor-receptor signaling and Rho GTPases to promote cell motility and invasion. In addition, p120-catenin probably plays multiple roles in cadherin switching, regulating Rho GTPases and stabilizing cadherins.

Citing Articles

A type of pancreatic cancer cells form cell clusters from a solitary condition in a primary ciliogenesis-dependent manner.

Shirakawa K, Nakazato R, Hara T, Uemura K, Ijaz F, Takahashi S Med Mol Morphol. 2025; .

PMID: 40069423 DOI: 10.1007/s00795-025-00428-0.


TMEM97 governs partial epithelial-mesenchymal transition of retinal pigment epithelial cells via the CTNND2-ADAM10 axis.

Li J, Nagasaka Y, Shen H, Zhou X, Ma J, Trevisan-Silva D Mol Ther Nucleic Acids. 2025; 36(1):102460.

PMID: 39995975 PMC: 11848774. DOI: 10.1016/j.omtn.2025.102460.


Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma.

Munoz M, Rosso M Cancers (Basel). 2025; 17(3).

PMID: 39941886 PMC: 11816061. DOI: 10.3390/cancers17030520.


Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial-Mesenchymal Transition.

Blaszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A Cancers (Basel). 2025; 17(2).

PMID: 39858010 PMC: 11764116. DOI: 10.3390/cancers17020228.


CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth.

Adekoya T, Smith N, Kothari P, Dacanay M, Li Y, Richardson R Cancers (Basel). 2025; 16(24.

PMID: 39766038 PMC: 11674668. DOI: 10.3390/cancers16244138.